Testing for BRAF V600E and MAP2K1 mutations is especially valuable in challenging cases where ECD may be confused with extracutaneous or disseminated juvenile xanthogranuloma because characteristic genetic aberrations favor the diagnosis of ECD. The gene discussed is BRAF; the disease is familial atrioventricular septal defect.